跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,131 条关于
“PI3K/AKT/mTOR”
全部
10,131
临床试验
7,176
药物
708
机构
84
资讯
2,163
7个月前
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M to Advance PI3K/AKT/mTOR Pathway Inhibitor PIKTOR
去年
Faeth Therapeutics Advances Novel Three-Pronged Approach for Metabolism-Driven Cancers with Promising Preclinical Results
上个月
Advanced Endometrial Cancer Pipeline Gains Momentum as ADCs, Immunotherapy and Targeted Combinations Reshape Treatment
去年
Cosmos Health Acquires Rights to Two Patented Anticancer Drugs Targeting Multiple Cancers
11个月前
Faeth Therapeutics Raises $25M to Advance PIKTOR Therapy After 80% Response Rate in Endometrial Cancer
去年
Gedatolisib Shows Promising 77-Month Overall Survival in Advanced Breast Cancer Phase 1b Trial
去年
Kazia Therapeutics Highlights Clinical Data and Pipeline Progress at November 2024 Corporate Presentation
11个月前
Faeth Therapeutics Reports Positive Phase 2 Results for Sapanisertib in Ovarian Cancer Treatment
11个月前
Frontier Medicines Unveils FMC-242, Novel PI3Kα/RAS Inhibitor Targeting Cancer's Most Common Genetic Drivers
9个月前
Rakovina Therapeutics Presents AI-Discovered CNS-Penetrant ATR/mTOR Dual Inhibitors at Neuro-Oncology Meeting
第 1 页,共 217 页
上一页
下一页